About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.26 (+3.29%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
Atividade de preço de PHAR
Último preço
$ 12,500
Variação (24h)
0,63 USD (5,31%)
Volume
29.02K
Volume (média 4 sem.)
-
Abertura
$ 11,85
Variação do dia
$ 11,85 - $ 12,50
Fechamento anterior
$ 11,87
Último negócio
28 Oct, 8:04 pm GMT+0
Atrasado
28 Oct, 8:04 pm GMT+0
PHAR price performance
Atrasado
28 Oct, 8:04 pm GMT+0
quote.marketSignals